Hasegawa et al. induced lymphangiogenesis in UUO model mice by injecting recombinant human VEGFC with an osmotic pump, significantly reducing macrophage infiltration, inflammatory cytokines and TGFβ levels, and alleviating renal fibrosis [81]. The gene discussed is VEGFC; the disease is renal fibrosis.